tranexamic acid – WOMAN-2 Trial

A woman holds a baby close to her chest.

Tranexamic acid cuts life-threatening bleeding after birth, but anaemia prevention is critical, studies show

Two papers from the WOMAN Trials Collaborators, published in The Lancet today, reveal important evidence on the effects of the drug tranexamic acid (TXA) on postpartum haemorrhage (PPH) and life-threatening …

Anaemia / Postpartum haemorrhage / Research

Looking ahead: What next for WHO’s roadmap to fight PPH and WOMAN Trials research to reduce maternal deaths

This article was written by the WOMAN Trials team. A year ago today, the WHO released its first roadmap to combat deaths from postpartum haemorrhage (PPH) – a condition …

Milestones / Research

Discussions on data, drafts and dissemination: The WOMAN Trials writing committee meeting

“Some of the most disadvantaged women took part in the WOMAN-2 Trial. They shared their experiences with us so that we could learn from them. “This is why we’ve been …

Staff Sehar Kanwal gives a dose of tranxamin to Waeema Abdullah, a patient suffering from postpartum haemorrhaging in the labor room at Holy Family Hospital on March 6, 2019 in Rawalpindi, Pakistan. Saiyna Bashir © Wellcome Trust

Sites

Tranexamic acid can reduce surgical bleeding and blood transfusions

Wider use of tranexamic acid (TXA) in surgery would improve surgical outcomes, avoid unnecessary blood transfusions and conserve blood stocks, according to an article published today in the British Medical …